InvestorsHub Logo
Followers 157
Posts 6403
Boards Moderated 1
Alias Born 08/06/2004

Re: Franz1969 post# 299889

Sunday, 02/21/2021 10:45:46 PM

Sunday, February 21, 2021 10:45:46 PM

Post# of 469087

Dr. Missling has said we will partner for Alzheimer's. Any revenue projections need to account for the partner's share.



Excellent point Franz and I agree, there will be plenty of revenues in the hundreds of Billions USD to share and then some. I don't think Missling will change his mind about partnering even if the treasury swells on Rett, Fraglile-X, PDD and PD revenues. The Alzheimer market is too huge to go it alone and will require a major pharma with a big foot print for world wide distribution.

If FDA and SAS approved it will be the largest revenue generating drug on the market. I'm going to speculate that SAS will be first due to their current positive arrangement with Anavex's 2-73 Blarcamesine.

Anavex will own the world wide CNS market.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News